Skip to main content

Aditxt, Inc.

ADTX
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001726711

No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Aditxt, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ADTX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders2527+2
Shares1.47M3.75M+2.28M (+155.8%)
Value$2.48M$2.01M−$467.4K (−18.9%)

New holders (8)

Institutions that held Aditxt, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ADTX in Q4 2021
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc117,658$63.0K0.00%
Warberg Asset Management LLC39,900$21.0K0.01%
Engineers Gate Manager LP36,050$19.0K0.00%
Biltmore Family Office, LLC30,000$16.0K0.00%
Jane Street Group, LLC12,574$7.00K0.00%
Meridian Wealth Management, LLC11,600$6.00K0.00%
Captrust Financial Advisors600$00.00%
Cutler Group LP100$00.00%

Sold out (6)

Institutions that held Aditxt, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ADTX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
CVI Holdings, LLC588,942$995.0K
Group One Trading, L.P.61,466$104.0K
Board of Trustees of The Leland Stanford Junior University15,228$26.0K
Wolverine Trading, LLC12,301$20.0K
Bank of America Corp2,947$5.00K
Tower Research Capital LLC (TRC)459$1.00K